Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of intralipid in acute tramadol poisoning
IRCT20210625051702N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2022
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of Intralipid 10% in tramadol overdose, sponsored by Tehran University of Medical Sciences. Started Sep 2022; status: completed.
02
Drugs
Intralipid 10%
03
Conditions
tramadol overdose
Beyond the preview
Go deeper on IRCT20210625051702N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210625051702N1.